This study's protocol was designed to assess the efficacy of JGT (Jaeumgeonbi-Tang) for chronic subjective dizziness.~This design of the study is a randomized, double-blind, parallel-group, placebo-controlled design.~Symptoms and quality of life of chronic subjective dizziness patients will be evaluated.~Dizziness severity and quality of life of the patients will be evaluated using DHI (Dizziness Handicap Inventory) (1) before treatment (baseline), (2) after 2 weeks, and (3) after 4 weeks of JGT treatment.~Blood samples of the patients will be gathered before and after JGT treatment for pathophysiological analysis.
The goal of this study is to assess the safety and efficacy of JGT (Jaeumgeonbi-Tang). A randomized, double-blind, parallel-group, placebo-controlled clinical trial was conducted and changes in symptoms and quality of life of the patients were evaluated.